Weekly Market Overview – July 13-19, 2026

IBM Earnings Warning Shocks Markets! Are Fundamentals Back in Focus?

The international stock markets experienced a volatile trading week as the second-quarter earnings season gained significant momentum. Market sentiment was primarily shaped by the surprising earnings warning from IBM. It reminded investors that after months of AI euphoria, company fundamentals and their outlooks are now once again determining price development.

At the same time, geopolitical risks returned to sharper focus. Developments surrounding Iran, in particular, and the associated uncertainties in the Middle East increased nervousness in the capital markets. The unpredictable political course of the US government under President Donald Trump further amplified this uncertainty. In such an environment, companies with stable business models, robust cash flows, and predictable earnings development are regaining importance.

IBM surprised the market with preliminary quarterly figures that fell short of expectations in both revenue and profit. Many corporate customers temporarily shifted their IT spending from software and consulting projects to investments in AI infrastructure such as servers, storage solutions, and semiconductors. At the same time, several larger customer orders were postponed. The result was a stock price drop of around 25%, marking the largest single-day loss in the company’s history and weighing on the entire technology sector.

From a fundamental perspective, however, this price reaction appears to have been significantly stronger than the deterioration in short-term business prospects would suggest. The market, especially in phases of increased uncertainty, often tends to overreact – both upwards and downwards. The development at IBM also illustrates that high valuations alone are not enough. Long-term, operational development, earnings quality, and a company’s ability to sustainably meet capital market expectations remain crucial.

In contrast, the healthcare sector once again confirmed its defensive strength, while within the technology sector, a significantly stronger differentiation between individual companies emerged. Industrial and defense stocks partially continued their consolidation of recent months.

Development of the UMBRELLA Strategy

The UMBRELLA Strategy recorded a mixed trading week. The first important quarterly reports led to a stronger differentiation between individual sectors and companies.

Following the preliminary earnings warning, the position in IBM was completely exited from the UMBRELLA Strategy, as the company’s short-term prospects have noticeably worsened and the stop-loss in the strategy was triggered. Long-term, IBM could still be well positioned in enterprise AI, hybrid cloud, and mission-critical software. However, the weaker operational outlook made the stock less attractive in the short term. The focus was therefore further directed towards NextEra Energy and MercadoLibre.

A new long-term growth stock, MercadoLibre, was added. This slightly increases the UMBRELLA Strategy’s exposure to the Latin American e-commerce company.

Apple was the strongest performer within the strategy this week. Key factors were continued investor confidence in the growing AI ecosystem, the robust services business, and attractive long-term growth prospects. Additionally, Apple received the RED HOT CHILI™ MUMAK award last week, reflecting the currently positive result of our analysis model.

The healthcare sector once again proved to be one of the most stable components of the strategy. Johnson & Johnson published better-than-expected quarterly figures and simultaneously raised its full-year 2026 outlook. This once again confirmed the resilience of its broadly diversified healthcare business – despite an overall more volatile market environment.

From our perspective, the figures underscore our above-average weighting of the healthcare sector. Especially in healthcare, the capital market currently seems to be paying more attention to classic fundamental factors such as earnings development, cash flow, balance sheet quality, and valuation.

Bayer and Revolution Medicines also performed positively during the week. Eli Lilly, however, declined slightly. This could also be due to the upcoming release of its quarterly figures. Who doesn’t sometimes want to secure profits in advance?

Tesla remained volatile, even quite weak towards the end of the week. Demand development in the electric vehicle market, price trends, and progress in autonomous driving ahead of this week’s quarterly figures had a negative impact.

NextEra Energy moved slightly positively and continues to benefit from long-term growth trends such as electrification, the expansion of renewable energies, and the increasing demand for electricity due to AI infrastructure and data centers.

Rheinmetall continued its consolidation of recent months. However, our long-term positive assessment has not changed. Structurally increasing European defense budgets, higher NATO investments, and a record order backlog continue to form a solid foundation for future development. It remains to be seen whether this positive assessment will also be reflected in the share price or if the stop-loss in the UMBRELLA Strategy will be triggered instead.